Pages that link to "Q34163525"
Jump to navigation
Jump to search
The following pages link to Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation (Q34163525):
Displaying 30 items.
- Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis (Q26770931) (← links)
- Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines (Q27002209) (← links)
- SIBLINGs and SPARC families: their emerging roles in pancreatic cancer (Q27027759) (← links)
- Loss of SPARC in bladder cancer enhances carcinogenesis and progression (Q30422650) (← links)
- A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2. (Q33407858) (← links)
- Investigation of manic and euthymic episodes identifies state- and trait-specific gene expression and STAB1 as a new candidate gene for bipolar disorder (Q34113404) (← links)
- Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis (Q36663581) (← links)
- Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics (Q36670886) (← links)
- Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels (Q37250548) (← links)
- Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models (Q37492629) (← links)
- Roles of SPARC in urothelial carcinogenesis, progression and metastasis (Q37687199) (← links)
- Stromal expression of SPARC in pancreatic adenocarcinoma (Q38108253) (← links)
- Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis. (Q38199932) (← links)
- The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal (Q38310416) (← links)
- The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer (Q38404425) (← links)
- The role of secreted protein acidic and rich in cysteine (SPARC) in cardiac repair and fibrosis: Does expression of SPARC by macrophages influence outcomes? (Q38638040) (← links)
- miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan (Q38711866) (← links)
- Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis. (Q38794591) (← links)
- Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line (Q38857169) (← links)
- Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis (Q38971921) (← links)
- The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease (Q38985417) (← links)
- Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. (Q39042485) (← links)
- The pancreatic cancer microenvironment: A true double agent. (Q39366753) (← links)
- Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. (Q47863448) (← links)
- Elimination of classically-activated macrophages in tumor-conditioned medium by alternatively-activated macrophages (Q48259732) (← links)
- SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy (Q50993362) (← links)
- Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women (Q58825129) (← links)
- The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment. (Q64947170) (← links)
- The effects of Losartan on abdominal wall fascial healing (Q87674650) (← links)
- GPCRs in pancreatic adenocarcinoma: Contributors to tumor biology and novel therapeutic targets (Q89725138) (← links)